Candoxatril reference standards are essential components for pharmaceutical laboratories engaged in analytical testing, method validation, and quality control of this therapeutic agent. As an orally active… Read more
Candoxatril reference standards are essential components for pharmaceutical laboratories engaged in analytical testing, method validation, and quality control of this therapeutic agent. As an orally active prodrug, candoxatril functions as a potent neutral endopeptidase inhibitor designed to modulate peptide metabolism and support blood pressure regulation, primarily investigated for its application in treating chronic heart failure. Because accurate quantification and characterization are critical during drug development, laboratories utilize high-quality reference materials to ensure consistency in impurity profiling and analytical assessments. This category provides access to the active pharmaceutical ingredient alongside related compounds, including specific stereoisomers and potential degradants like N-nitroso candoxatril. By utilizing these characterized reference standards, researchers can reliably detect, identify, and quantify impurities throughout the drug synthesis and manufacturing lifecycle, ensuring adherence to regulatory guidelines for safety and potency.